1Department of Medicine, Stroger Hospital, Cook County Bureau of Health Services, Chicago, Illinois.
2Hektoen Institute of Medicine/Cook County Health and Hospitals System, Chicago, Illinois.
J Womens Health (Larchmt). 2019 Aug;28(8):1083-1093. doi: 10.1089/jwh.2018.7454. Epub 2019 May 17.
To identify factors associated with incarceration among women and examine the relationship between incarceration and human immunodeficiency virus (HIV)-related outcomes. We analyzed longitudinal data from 3324 women (2372 with HIV and 952 uninfected) from 2007 to 2016 in the Women's Interagency HIV Study, a U.S. cohort of women with and without HIV. Lifetime history of incarceration before first study visit was used as the outcome and then as a predictor for HIV outcomes and mortality. Using multivariable models, we assessed associations between socio-demographic, behavioral, and clinical characteristics and incarceration, and between incarceration and HIV outcomes, including mortality. Overall, 1256 (38%) of women reported ever being incarcerated. Women who had a history of drug use had a 44% greater prevalence of incarceration compared with those who did not use drugs. Sexual minority women and women who experienced physical and sexual abuse had a 47% and 28%, respectively, greater prevalence of incarceration than heterosexual women and those not abused. For the 862 women with HIV and a history of incarceration, having an incarceration history was independently associated with less viral suppression (adjusted prevalence ratios = 0.95; confidence intervals [CI]:0.90-1.00 = 0.04) and higher likelihood of death (adjusted hazard ratios = 1.39; CI:1.04-1.86 = 0.03). Incarceration is common in this cohort and may put women with HIV at increased odds of worse HIV outcomes and mortality than those without a history of incarceration. Addressing the intersecting epidemics of HIV, substance use, and incarceration by providing needed treatment and resources and avoiding criminalization may improve health outcomes in vulnerable women with HIV.
为了确定与女性监禁相关的因素,并研究监禁与人类免疫缺陷病毒(HIV)相关结果之间的关系。我们分析了 2007 年至 2016 年期间来自妇女机构间 HIV 研究(一项针对有和无 HIV 的美国妇女队列)的 3324 名女性(2372 名 HIV 阳性和 952 名未感染)的纵向数据。在首次研究就诊前的终身监禁史被用作结果,然后用作 HIV 结果和死亡率的预测因子。使用多变量模型,我们评估了社会人口统计学、行为和临床特征与监禁之间的关联,以及监禁与 HIV 结果(包括死亡率)之间的关联。总体而言,1256 名(38%)女性报告曾被监禁。有吸毒史的女性入狱率比没有吸毒史的女性高 44%。性少数女性和经历过身体和性虐待的女性入狱率分别比异性恋女性和未受虐待的女性高 47%和 28%。对于 862 名有 HIV 病史和入狱史的女性,有入狱史与病毒抑制率降低(调整后流行率比[PR] = 0.95;95%置信区间[CI]:0.90-1.00 = 0.04)和死亡可能性增加(调整后风险比[HR] = 1.39;95%CI:1.04-1.86 = 0.03)独立相关。在这个队列中,监禁很常见,与没有入狱史的女性相比,有入狱史的 HIV 女性可能更有可能出现 HIV 结果恶化和死亡的风险。通过提供必要的治疗和资源,并避免定罪,解决 HIV、药物使用和监禁的交叉流行,可能会改善 HIV 脆弱女性的健康结果。